News
Additional clinical sites in the EU will assess HT-001 for the treatment of skin toxicities associated with EGFRi.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback